Drugs

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

8 days ago   |   By Xconomy

The treatment landscape for lung cancer has shifted significantly over the past few years , and more changes could be on the way. At the World Conference on Lung Cancer in Barcelona this weekend a number of drug makers trotted out some of their latest advances in immunotherapy, targeted pills, drug combinations, and more. Xconomy rounded up some of the most noteworthy headlines and put them in context below. Spotlight on KRAS Over the past year, a drug called AMG 510, from Amgen has caused quite a stir, and for good reason. It's the first drug to inhibit...
Read more ...

 

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer

8 days ago   |   By Fierce Biotech

BARCELONA-Now within the ownership of Eli Lilly, Loxo Oncology has presented new data at the World Conference on Lung Cancer for its RET inhibitor LOXO-292 as it plots an NDA in the coming months.
Read more ...

 


Search by Tags

   Drugs      Drug      Cancer      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      American Society of Clinical Oncology      AMG-510      Amgen      Andrew Berens      AstraZeneca      Atezolizumab      Blueprint Medicines      Cancer immunotherapy      Chemotherapy      Clinical trials      Colorectal Cancer      Data      Durvalumab      Eli Lilly      Imfinzi      Immunotherapy      Kennen MacKay      Keytruda      KRAS      Life Sciences      Loxo Oncology      Lung Cancer      Medullary thyroid cancer      Merck      Mirati Therapeutics      Non-Small Cell Lung Cancer      Pembrolizumab      RET fusion      Roche      Small cell lung cancer      SVB Leerink      World Conference on Lung Cancer  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Why Menlo Ventures Backed Its First Construction Tech Firm

Why Menlo Ventures Backed Its First Construction Tech Firm

Fieldwire , whose mobile app helps builders and construction crews coordinate their work, announced today it has lined up a total of $33.5 million across two newly disclosed... Read more ...

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

One Texas-based healthcare software business has acquired another in an all-cash deal worth $36.5 million, the companies announced late Monday. Irving, TX-based HMS Holdings... Read more ...

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

Anticipated FABRIC topology at the end of construction. The National Science Foundation is funding a collaborative effort to create a nationwide research infrastructure that... Read more ...

Automated Trucking Company TuSimple Adds $120M More From Investors

Automated Trucking Company TuSimple Adds $120M More From Investors

UPS, the global package delivery giant, took a minority stake this summer in TuSimple, a self-driving trucking company, but didn't reveal financial details. On Tuesday, the San... Read more ...

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acquired by patients with compromised immune systems, has acquired the rights to... Read more ...

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Denmark's neuroscience-focused pharma firm Lundbeck has agreed to pay $1.95 billion to acquire Seattle-based Alder BioPharmaceuticals to boost its late-stage pipeline and... Read more ...

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

A diagram of the layout and major features of the KATRIN experimental facility at the Karlsruhe Institute of Technology. (Credit: Karlsruhe Institute of Technology) Note: This... Read more ...

101601 CTRI CCR Operations Manager

CLINICAL TRANSLA RESEARCH INST Salary commensurate with qualifications and experienceFiling Deadline: Tue 10/1/2019... Read more ...

101667 Sr. Licensed Vocational Nurse

CLINICAL TRANSLA RESEARCH INST Salary commensurate with qualifications and experienceFiling Deadline: Tue 9/24/2019... Read more ...

Improvement of Fab expression by screening combinatorial synonymous signal...

Antibody fragments can be expressed in Escherichia coli, where they are commonly directed to the periplasm via Sec pathway to enable disulphide bridge formations and correct... Read more ...